It states that " The aim of treatment is to bring the plasma ferritin concentration within the reference range(< 200 ug/L) and the plasma iron < 30 umol/L. The plasma iron begins to fall only when available iron stores are depleted which may take 1-2 years of therapy in patients with markedly increased iron stores".
Thanks for your replies so far and references to guidelines, indicating some lack of consensus. I was aware of some of these. However, guidelines are sometimes not always followed and so I was particularly interested to know whether most laboratories were measuring iron and transferrin as well as ferritin.
richard,
please could you tell us what this book says?
many thanks in advance,
joseph
Dr Joseph Watine, PH, AIHP, PharmD, AAHU, EurClinChem
Laboratoire de Biologie Polyvalente
Centre Hospitalier Général
12027 Rodez Cedex 9
France
________________________________
Date: Wed, 2 Apr 2008 14:28:41 +0100
From:
[log in to unmask]Subject: Re: Monitoring haemochromatosis treatment
To:
[log in to unmask]See also page 66 in :
Liver Disease and Laboratory Medicine. I. McFarlane, A. Bomford, and R. Sherwood. London: ACB Venture Publications, 2000.
with best wishes
Richard
Richard Mainwaring-Burton
Consultant Biochemist
Queen Mary's Hospital
Sidcup, Kent
020-8308-3084
-----Original Message-----
From: Joseph WATINE [
mailto:[log in to unmask]]Sent: 02 April 2008 14:12
To:
[log in to unmask]Subject: Re: Monitoring haemochromatosis treatment
In France, the guidelines published by "la Haute Autorité de Santé" ("HAS") recommend that ferritin (and hemoglobin) be measured in this context. The targets to be reached are "not below 11" for hemoglobin and "below 50" for ferritin. According to this governmental organisation, iron and transferrin saturation are useless in this context.
Some other organisations do recommend to measure iron and transferrin saturation and the target to be reached is generally "below 50%" for transferrin saturation.
I would rather trust these other organisations more than the "HAS", because it seems to me that if transferrin saturation is not monitored, high levels of free iron might cause some harm to the patients.
Best regards,
Dr Joseph Watine, PH, AIHP, PharmD, AAHU, EurClinChem
Laboratoire de Biologie Polyvalente
Centre Hospitalier Général
12027 Rodez Cedex 9
France
_________________________________________________________________
Créez votre disque dur virtuel Windows Live SkyDrive, 5Go de stockage gratuit !
http://www.windowslive.fr/skydrive/------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.ukList Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.htmlList Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/ ---------------------------------------------------------------------
-
-
-
-
-
-
The information in this e-mail and any attachments is confidential
and
is
intended for the attention and use of the named addressee(s). It
must
not
be disclosed to any other person without our authority. If you are
not
the intended recipient, or a person responsible for delivering it to
the
intended recipient or are aware that this e-mail has been sent to
you
in
error, you are not authorised to and must not disclose, copy,
distribute,
or retain this message or any part of it.
We sweep all outgoing messages for the presence of computer
viruses.
However, we cannot accept any responsibility for any loss or
damage
to
your systems due to viruses or malicious code not detected.
The statements and opinions expressed in this message are
those of
the
author and do not necessarily reflect those of the organisations
within
the Cornwall & Isles of Scilly Health Community.
This email may be disclosed under the Freedom of Information
Act
2000
or
the Environmental Information Regulations 2004.
---------------------------------------------------------------------
-
-
-
-
-
-